UK halts trial of hydroxychloroquine in COVID-19 patients after no benefit found

British scientists halted a large trial on Monday that had been exploring the use of the anti-malaria drug hydroxychloroquine in patients with the pandemic disease COVID-19 after initial results showed no evidence of benefit.